Pulmonary or respiratory drug delivery market to reach $114.23 billion by 2030 at 8.6% CAGR, driven by increasing prevalence of pneumonia.
Read More
Pulmonary drugs market to reach $74.14 billion by 2030 at 5.4% CAGR, driven by increasing prevalence of respiratory diseases.
Read More
Pulmonary arterial hypertension market to reach $13.75 billion by 2030 at 8.5% CAGR, driven by rising clinical trials for drug development.
Read More
Psoriatic arthritis treatment market to reach $20.62 billion by 2030 at 9.5% CAGR, driven by increase in healthcare spending.
Read More
Psoriasis biosimilars market to reach $13.79 billion by 2030 at 11.0% CAGR, driven by rising psoriatic arthritis diagnosis rates.
Read More
Psoriasis market to reach $44.79 billion by 2030 at 9.3% CAGR, driven by rise in the prevalence of psoriasis patients.
Read More
Pseudomonas aeruginosa infection treatment market to reach $3.89 billion by 2030 at 8.0% CAGR, driven by increasing incidence of comorbidities such as pneumonia and cystic fibrosis.
Read More
Pruritus therapeutics market to reach $16.88 billion by 2030 at 6.6% CAGR, driven by rise in the incidence of dermatological disorders.
Read More
The global nausea medicine market to reach $4.5 billion by 2030 at 6.9% cagr, driven by rising consumption of unhealthy diets.
Read More
Natural Killer (NK) Cell Therapeutics Market Outlook 2026–2035: Growth Drivers and Industry Forecast
Natural killer cell therapeutics market to reach $6.9 billion by 2030 at 11.9% cagr, driven by rising prevalence of cancer and demand for advanced immunotherapies.
Read More